---
layout: page
title: Four Pillars of Drug Discovery
permalink: /pillars.html
---

<div class="site-description">
    <p>
        RP3 has established three of the four pillars of drug discovery: <a href="">People</a>, <a href="">Platform</a> and <a href="">Pipeline</a>. Current goal of RP3 is the <a href="">Translation</a> of its drugs in human clinical trials.
    </p>
</div>
{% include image_caption.html imageurl="https://raw.githubusercontent.com/tosingfung/images/master/image-20230910095541594.png"  %}

---

# Pillar I: People

![image-20230910114849560](https://raw.githubusercontent.com/tosingfung/images/master/image-20230910114849560.png)

- International team of drug discovery scientists
- Successful **talent recruitment** in diversified disciplines by RP3 has been completed
- Total staff is currently 65 (**critical mass!**)
- [Click here for a full list of RP3 members](/people)

---

# Pillar II: Platform

![image-20230910135827999](https://raw.githubusercontent.com/tosingfung/images/master/image-20230910135827999.png)

- Each platform fully equipped and staffed
- Allows RP3 to conduct drug development from target validation to IND candidate nomination
- **Compound Screening Platform**
  - Semi-automated HTS center
  - 20 screening assays available
  - 96 and 384 plate formats available
  - Internal compound library being built
- **Analytical Chemistry Platform**
  - Full chemical analysis of compounds
  - NMR, MS, LC-MS, LC-MS/MS, HPLC
- **Pharmacology Platform**
  - Pharmacokinetics of drugs in rodents
  - In vivo behavioral & musculoskeletal disease models in mice and rats established
- **Medicinal Chemistry Platform**
  - Over 500 new chemical entities synthesized
  - Deuterium-substitution based chemistry
  - Peptide based chemistry  

---

# Pillar III: Pipeline

![image-20230910135453970](https://raw.githubusercontent.com/tosingfung/images/master/image-20230910135453970.png)

- **Drugs for cognitive regeneration**
  - Preserving the brain extracellular matrix using small molecule drugs as a strategy for blocking neural degeneration
  - Development of GPCR agonists as a stratagem for curing tinnitus & amblyopia
  - Development of GPCR antagonists for alleviating epilepsy
  - In-vitro and in-vivo assay platforms for assessing drug efficacy for brain disorders
  - Mechanism-based studies on the role of orphan GPCRs in brain health
- **Drugs for muscle skeletal regeneration**
  - Development of natural small molecules to promote osteoporotic fracture healing
  - Study the role of mesenchymal cells in cartilage repair
  - Development of enterotoxins as drugs to promote osteoporotic fracture healing



---

# Pillar IV: Translation (In Progress)

![image-20230910142308241](https://raw.githubusercontent.com/tosingfung/images/master/image-20230910142308241.png)
